Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape Enhancers
Open Access
Abstract
The toxic moiety of almost all protein-based targeted toxins must enter the cytosol of the target cell to mediate its fatal effect. Although more than 500 targeted toxins have been investigated in the past decades, no antibody-targeted protein toxin has been approved for tumor therapeutic applications by the authorities to date. Missing efficacy can be attributed in many cases to insufficient endosomal escape and therefore subsequent lysosomal degradation of the endocytosed toxins. To overcome this drawback, many strategies have been described to weaken the membrane integrity of endosomes. This comprises the use of lysosomotropic amines, carboxylic ionophores, calcium channel antagonists, various cell-penetrating peptides of viral, bacterial, plant, animal, human and synthetic origin, other organic molecules and light-induced techniques. Although the efficacy of the targeted toxins was typically augmented in cell culture hundred or thousand fold, in exceptional cases more than million fold, the combination of several substances harbors new problems including additional side effects, loss of target specificity, difficulties to determine the therapeutic window and cell type-dependent variations. This review critically scrutinizes the chances and challenges of endosomal escape enhancers and their potential role in future developments.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (GI 1135/1-1)
This publication has 187 references indexed in Scilit:
- Diving through Membranes: Molecular Cunning to Enforce the Endosomal Escape of Antibody-Targeted Anti-Tumor ToxinsAntibodies, 2013
- Efficacy of an adapted granzyme B-based anti-CD30 cytolytic fusion protein against PI-9-positive classical Hodgkin lymphoma cells in a murine modelBlood Cancer Journal, 2013
- Plasmonic nanobubble-enhanced endosomal escape processes for selective and guided intracellular delivery of chemotherapy to drug-resistant cancer cellsBiomaterials, 2012
- Toxin-Based Therapeutic ApproachesToxins, 2010
- Sensitivity of Cancer Cells to Truncated Diphtheria ToxinPLOS ONE, 2010
- Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivoBritish Journal of Cancer, 2009
- Multi-Modality Therapeutics with Potent Anti-Tumor Effects: Photochemical Internalization Enhances Delivery of the Fusion Toxin scFvMEL/rGelPLOS ONE, 2009
- Delivery of Macromolecules Using Arginine-Rich Cell-Penetrating Peptides: Ways to Overcome Endosomal EntrapmentThe AAPS Journal, 2009
- Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptideNucleic Acids Research, 2007
- Effect of carboxylic ionophores on lysosomal protein degradation in rat hepatocytesExperimental Cell Research, 1983